Genfit

Genfit S.A.
Stock Exchange Other OTC
EPS
$1.4
Market Cap
$756.67 M
Shares Outstanding
28.05 M
Public Float
-
Genfit S.A.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
28.05 M
Public Float
-
Genfit S.A.
Stock Exchange Euronext Paris
EPS
EUR1.25
Market Cap
EUR674.41 M
Shares Outstanding
38.83 M
Public Float
28.4 M

Profile

Address
Parc Eurasante
Loos Nord-Pas-de-Calais 59120
France
Employees -
Website http://www.genfit.com
Updated 07/08/2019
Genfit SA is a biopharmaceutical company involved in drug discovery and development for the early diagnosis, prevention and treatment of cardiometabolic diseases. The company focuses on the discovery and development of drug candidates in areas of high unmet medical needs corresponding to a lack of suitable treatments. Its research and development efforts are focused on medicines to market for patients with metabolic, inflammatory, autoimmune and fibrotic diseases, that affect the liver.

Financials

View All

Jean-François Mouney
Chairman & Chief Executive Officer
Jean-Yves Bacon
Director